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Yeast phosphatidylinositol-transfer protein (Sec14p) is essential for Golgi secretory function and
cell viability. This requirement of Sec14p is relieved by genetic inactivation of the cytidine
diphosphate-choline pathway for phosphatidycholine (PtdCho) biosynthesis. Standard pheno-
typic analyses indicate that inactivation of the phosphatidylethanolamine (PtdEtn) pathway for
PtdCho biosynthesis, however, does not rescue the growth and secretory defects associated with
Sec14p deficiency. We now report inhibition of choline uptake from the media reveals an efficient
“bypass Sec14p” phenotype associated with PtdEtn-methylation pathway defects. We further
show that the bypass Sec14p phenotype associated with PtdEtn-methylation pathway defects
resembles other bypass Sec14p mutations in its dependence on phospholipase D activity. Finally,
we find that increased dosage of enzymes that catalyze phospholipase D-independent turnover of
PtdCho, via mechanisms that do not result in a direct production of phosphatidic acid or
diacylglycerol, effect a partial rescue of sec14-1ts-associated growth defects. Taken together, these
data support the idea that PtdCho is intrinsically toxic to yeast Golgi secretory function.
INTRODUCTION
Sec14p represents the major phosphatidylinositol/
phosphatidycholine (PtdIns/PtdCho) transfer protein in
yeast (Bankaitis et al., 1989, 1990). Analyses of mutations that
allow yeast to survive in the absence of the normally essen-
tial Sec14p demonstrate that Sec14p integrates phospholipid
metabolism with the phospholipid requirements of Golgi
secretory function (Cleves et al., 1991b; Kearns et al., 1998).
Our early hypotheses concerning the essential role of Sec14p
in stimulating yeast Golgi secretory processes posited a
Sec14p-mediated modulation of an intrinsic toxicity of Ptd-
Cho to Golgi function (Cleves et al., 1991a,b; McGee et al.,
1994). One key finding that led to this hypothesis was that
genetic inactivation of the cytidine diphosphate (CDP)-cho-
line pathway for PtdCho biosynthesis effects “bypass
Sec14p,” whereas defects in the PtdEtn-methylation path-
way do not. These effects were observed irrespective of the
choline content of the medium upon which the bypass
Sec14p mutants were selected and scored at 37°C (Cleves et
al., 1991b). Although issues of differential localization of
these two pathways were suggested to account for this
puzzling specificity, the concept was also raised that meta-
bolic flux through the CDP-choline pathway exerts its toxic
effects by consuming a critical metabolite (McGee et al.,
1994). Demonstrations that the PtdCho-bound form of
Sec14p down-regulates CDP-choline pathway activity em-
phasizes the antagonistic relationship between the CDP-
choline pathway and Golgi secretory function (McGee et al.,
1994; Skinner et al., 1995; Phillips et al., 1999). This body of
evidence led to our proposal that DAG is a key stimulator of
Golgi secretory function (Kearns et al., 1997, 1998).
We now report that defects in PtdCho biosynthesis via the
PtdEtn-methylation pathway can also effect bypass Sec14p.
We demonstrate that sec14-1ts mutants engage in a cycle of
PtdCho turnover and recapture of excreted choline that
activates salvage of the released choline via the CDP-choline
pathway. This cycle obscures the bypass Sec14p effects that
are associated with PtdEtn-methylation pathway dysfunc-
tion. Conditions of either a genetic or environmental nature
that prevent active choline salvage endow Sec14p-indepen-
dent growth to yeast mutants deficient in PtdEtn-methyl-
ation pathway activity. The bypass Sec14p associated with
PtdEtn-methylation pathway defects resembles all other
known pathways for bypass Sec14p in that it depends on an
active phospholipase D (PLD) (Sreenivas et al., 1998; Xie et
al., 1998). Finally, we demonstrate that increased rates of
PtdCho degradation via pathways that are independent of
PLD and do not result in phosphatidic acid (PtdOH) or‡ Corresponding author. E-mail address: bktis@med.unc.edu.
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diacylglycerol (DAG) formation, also exert a partial suppres-
sion of sec14-1ts-associated growth defects.
Taken together, these data support the concept that PtdCho
is intrinsically toxic to yeast Golgi function, and that a primary
function of Sec14p is to maintain a Golgi PtdCho composition
that is permissive for efficient transport of proteins from this
organelle. This conclusion supports our early proposals that
elevated PtdCho in Golgi membranes is incompatible with
Golgi secretory function (Cleves et al., 1991a,b).
MATERIALS AND METHODS
Yeast Strains, Plasmids, and Genetic Techniques
Yeast strains used in this study are listed in Table 1. Media and
standard genetic techniques have been described (Ito et al., 1983;
Rothstein, 1983; Sherman et al., 1983). Plasmid shuffle assays for
complementation of sec14D were performed with yeast strain
CTY1461 (Table 1) as described (Lopez et al., 1994; Phillips et al.,
1999). The plasmids used in this study are listed in Table 2. Further
details are available from us upon request.
Isolation of css Mutations
sec14-1ts strains were cultured in liquid I1C2 media at 26°C, culture
aliquots were spread plated onto I1C2 agar, and the plates were
Table 1. Yeast strains
Strain Genotype Origin
CTY182 MATa, ura3-52, Dhis3-200, lys2-801am Bankaitis et al., (1989)
CTY1-1A MATa, ura3-52, Dhis3-200, lys2-801am, sec14-1ts Bankaitis et al., (1989)
CTY2-1C MATa, ade2-101, sec14-1ts Cleves et al., (1989)
CTY102 MATa, ura3-52, Dhis3-200, lys2-801am, sec14-1ts, pct1-2 Cleves et al., (1991b)
CTY950 MATa, CTY1-1A/YEplac195 This study
CTY1374 MATa, CTY1-1A, cho2 This study
CTY1375 MATa, CTY1-1A, opi3 This study
CTY1376 MATa, CTY1-1A, cho2, hnmlD319<URA3 This study
CTY1377 MATa, CTY1-1A, opi3, hnmlD319<URA3 This study
CTY1461 MATa, ura3-52, Dhis3-200, ade2, ade3, leu2, sec14Dp<hisG, YEp(SEC14) This study
CTY1469 MATa, CTY1461, hnmlDp<URA3 This study
CTY1470 MATa, CTY1461, hnmlDp<URA3, cho2D409<HIS3 This study
CTY1471 MATa, CTY1461, hnmlDp<URA3, opi3D93<HIS3 This study
CTY1473 MATa, ura3-52, Dhis3-200, sec14-1ts, ino4 This study
CTY1485 MATa, ura3-52,Dhis3-200, lys2-801am, Dtrpl, sec14-1ts, hnmlD319<URA3, spo14D<URA3, opi3 This study
CTY1498 MATa, CTY182, hnmlDp<URA3 This study
CTY1499 MATa, CTY1-1A, hnmlDp<URA3 This study
CTY1500 MATa, CTY1-1A, cho2, hnmlDp<URA3 This study
CTY1501 MATa, CTY1-1A, opi3, hnm1Dp<URA3 This study
CTY1502 MATa, CTY182, hnmlDp<HIS3 This study
CTY1504 MATa, CTY1-1A, cho2, hnmlDp<HIS3 This study
CTY1505 MATa, CTY1-1A, opi3, hnmlDp<HIS3 This study
CTY1506 MATa, CTY182, hnmlDp<HIS3, spo14D<URA3 This study
CTY1507 MATa, CTY1-1A, hnmlDp<URA3, spo14D<HIS3 This study
CTY1512 MATa, CTY1-1A, cho2, hnmlDp<HIS3,, spo14D<URA3 This study
CTY1513 MATa, CTY1-1A, opi3, hnmlDp<HIS3,,spo14D<URA3 This study
CTY1519 MATa, CTY1485, YCp(SPO14) This study
CTY1520 MATa, CTY1485, YCp(spo14K3H) This study
CTY1521 MATa, CTY1485, YCp(spo14DN) This study
CTY1522 MATa, CTY1485, YEp(spo14K3H) This study
CTY1523 MATa, CTY1485, YEp(spo14DN) This study
CTY1528 MATa, CTY1-1A/YEp(PPGK<PLB1) This study
CTY1529 MATa, CTY1-1A YEp(PIK1) This study
CTYD174 MATa, ura3-52, Dhis3-200, lys2-801am, TRP1, sec14-1ts, css1
MATa, ura3-52 Dhis3-200 lys2-801am Dtrp1 sec14-1ts cho2D<HIS3
This study
CTYD175 MATa, ura3-52, Dhis3-200, lys2-801am, ADE2, TRP1, sec14-1ts, css2
MATa, ura3-52 Dhis3-200 LYS2 ade2 Dtrp1 sec14-1ts opi3D<URA3
This study
CTYD176 MATa, ura3-52, Dhis3-200, lys2-801am, sec14-1ts, ino4D<URA3
MATa, ura3-52 Dhis3-200 LYS2 sec14-1ts css3
Table 2. Plasmids
Plasmid Designation Origin
YCp(OPI3, HISD3) pCTY749 This study
YCp(CHO2, URA3) pCTY750 This study
YCp(INO4, URA3) pCTY780 This study
YCp(SPO14, URA3) pCTY747 This study
YCp(SPO14K3H, HISD3) pCTY793 This study
YCp(SPO14DN, HISD3) pCTY794 This study
YEp(SPO14K3H, HISD3) pCTY795 This study
YEp(SPO14DN, HISD3) pCTY796 This study
YCp(PPGK<PLB1, URAD3) pCTY775 This study
YEp(PIK1, URAD3) pCTY797 Walch-Solimena and
Novick (1999)
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incubated at 35°C for 5 d. Revertant colonies were isolated, patched
onto I1C2 plates, and replica plated onto I1C1 and I1C2 agar
plates. The replicas were incubated at 37°C for 36 h and scored for
growth relative to the sec14-1ts control strain. The revertants whose
growth was improved on I1C2 agar but not on I1C1 agar were
saved. These css mutants were subsequently confirmed by their
ability to form single colonies on I1C2, but not I1C1, agar at 35°C.
Invertase Assay and Immunoprecipitation of
Carboxypeptidase Y (CPY)
Invertase assays were performed as described by Salama et al.
(1990). CPY was precipitated from cell-free lysates prepared from
radiolabeled yeast strains exactly as described previously (Bankaitis
et al., 1989; Cleves et al., 1991; Fang et al., 1996).
Briefly, appropriate yeast strains were grown in Wickerham’s
minimal media to mid-logarithmic phase at 26°C, shifted to 37°C for
2 h, and pulse-radiolabeled with 35S-labeled amino acids for 30 min.
Proteins were precipitated with trichloroacetic acid and solubilized
in SDS buffer. Immunoprecipitation of CPY antigen, and separation
and analysis of different CPY species by SDS-PAGE and phospho-
rimaging have been described (Bankaitis et al., 1989; Cleves et al.,
1991; Fang et al., 1996).
Phospholipid Determinations
For measurements of steady-state phospholipid compositions, ap-
propriate yeast strains were grown for five to six generations at 26°C
in I1C2 or I1C1media in the presence [32P]orthophosphate (10
mCi/ml). In pulse-radiolabeling experiments, appropriate yeast
strains were grown in I1C2 or I1C1 media to mid-logarithmic
phase at 26°C, and shifted to 33.5°C for 2 h. [32P]Orthophosphate
was then added into the media to 10 mCi/ml and cells incubated in
the presence of the label at 33.5°C for 20 min. Incorporation of label
was terminated by addition of trichloroacetic acid to 5% and phos-
pholipid extraction, resolution by two-dimensional paper chroma-
tography, and quantification of individual phospholipid species
was performed as described in detail elsewhere (McGee et al., 1994;
Rivas et al., 1999; Li et al., 2000).
RESULTS
Isolation of Mutations that Suppress sec14-1ts
Growth Defects in a Choline-sensitive Manner
We previously described the rationale for a genetic screen
designed to identify genes involved in promoting PtdCho
turnover (Xie et al., 1998). Briefly, defects in the CDP-choline
pathway for PtdCho biosynthesis relieve the normally es-
sential Sec14p requirement for Golgi secretory function and
cell viability (Figure 1A; Cleves et al., 1991a,b). This bypass
Sec14p effect is observed even when yeast are grown in
choline-free (C2) media (Cleves et al., 1991b). Under these
conditions, the CDP-choline pathway simply serves as a
salvage pathway that scavenges the choline liberated by
PtdCho turnover and reuses it in a round of PtdCho resyn-
thesis. Because yeast cannot synthesize choline de novo, this
cycle does not contribute to net cellular PtdCho synthesis.
On the basis of those data we reasoned that defects in
pathways for PtdCho turnover that liberate free choline
should impede metabolic flux through the CDP-choline
pathway when yeast are grown in C2, but not in C1, media.
Such defects elicit bypass Sec14p phenotypes that are sensi-
tive to choline in the medium (Figure 1A).
One of the genes we expected to identify in this screen for
choline-sensitive suppressors of sec14 defects (css mutations)
was the structural gene encoding phospholipase D (PLD). A
direct test of this predicted outcome was made possible by
finding that the nonessential SPO14 is the PLD structural
gene (Rose et al., 1995). Counter to expectations, we found
that PLD activity is unconditionally essential for all known
mechanisms of bypass Sec14p (Xie et al., 1998). This finding
indicated that the role of PLD in bypass Sec14p is more
complex than anticipated, and suggested that we did not
fully comprehend the relationship between PtdCho metab-
olism and Sec14p function in yeast.
To further investigate how PtdCho metabolism might in-
terface with Sec14p function, we isolated and characterized
css mutations (see MATERIALS AND METHODS). A total
of 43 independent and spontaneously arising css mutants
was isolated. Standard dominance tests, meiotic segregation,
and genetic complementation analyses were performed to
assign these mutations into complementation groups. A dif-
ficulty we encountered in such analyses of css mutants was
that growth of all sec14-1ts css mutants is extremely poor on
I1C2 plates at 37°C. Indeed, these mutants fail to form
single colonies under these conditions, although single col-
onies are formed at 35°C. Reliable visualization of the im-
proved residual growth of sec14-1ts css mutants on I1C2
plates under conditions restrictive for growth of sec14-1ts
parental strains required replica plating at 37°C (Figure 3A).
Streak plating of sec14-1ts css mutants for isolated colonies at
35°C was also used to confirm the results gathered by replica
plating.
A combination of dominance tests and complementation
analyses demonstrated that all 43 css mutations are recessive
to wild type and define three complementation groups.
These were designated css1 (37 representatives), css2 (2 rep-
resentatives), and css3 (4 representatives), respectively. Mei-
otic segregation analyses further demonstrated that each
individual complementation group corresponds to a linkage
group, indicating that the 43 css mutations identify three
unlinked genes.
As shown in Figure 1B, the growth of all sec14-1ts css
mutants is exquisitely sensitive to exogenous choline at re-
strictive temperatures. Introduction of low concentrations of
choline into agar plates (5 mM final concentration) results in
a strong inhibition of growth, whereas increasing exogenous
choline to a concentration of 10 mM inhibits growth com-
pletely (Figure 1B). Choline concentrations as low as 1 mM
also detectably inhibit growth. By contrast, exogenous eth-
anolamine (1 mM) has no effect on the growth of sec14-1ts css
strains, irrespective of whether inositol is present in the
medium (unpublished data). Finally, css3 mutants, although
inositol prototrophs, nonetheless require inositol for mani-
festation of the css phenotype. All sec14-1ts css3 mutants fail
to grow on I2C2 medium at 37°C. Depletion of inositol from
the medium has no effect on growth of sec14-1ts css1 and
sec14-1ts css2 mutants, however (Figure 1B).
css Mutants Are Defective in PtdEtn-Methylation
Pathway Activity
To investigate whether css mutations influence PtdCho turn-
over, we first analyzed the bulk phospholipid profiles of css
mutant strains (see MATERIALS AND METHODS). Unex-
pectedly, all css mutants displayed profiles diagnostic of
compromised activity of the PtdEtn-methylation pathway
for PtdCho biosynthesis. Even in I1C1 media, where the
CDP-choline pathway is a major contributor to PtdCho bio-
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synthesis, all css mutants exhibit reduced PtdCho levels.
Moreover, css1 mutants exhibit a twofold increase in bulk
PtdEtn, whereas css2 mutants accumulate phosphatidyl-
monomethylethanolamine (PMME; Figure 2A). PMME is an
intermediate in the conversion of PtdEtn to PtdCho via the
PtdEtn-methylation pathway. In I1C2 media, where the
PtdEtn-methylation pathway is the sole route for net syn-
thesis of bulk PtdCho, defects in the activity of this pathway
are most dramatic. Under these conditions, we record a
fourfold reduction in bulk PtdCho and a threefold elevation
in bulk PtdEtn in css1 mutants, whereas css2 mutants exhib-
ited a 30-fold reduction in bulk PtdCho and 30-fold eleva-
tions in levels of both PMME and phosphatidyldimethyleth-
anolamine (PDME; Figure 2B). PDME is produced from
PMME, and is the immediate precursor to PtdCho in the
PtdEtn-methylation pathway (Figure 1A). Finally, css3 mu-
tants display only modest reductions in bulk PtdCho and
modest accumulations of PtdEtn under these conditions
(Figure 2B). Inositol depletion has no significant effect on the
phospholipid profiles of css1 and css2 strains, regardless of
whether choline is present in the medium or not. Inositol
depletion evokes a significant reduction in bulk PtdIno lev-
els in css3 mutants, however (our unpublished data).
CSS Genes Represent Structural Genes for Enzymes
and Regulators of the PtdEtn-Methylation Pathway
The phospholipid profiles obtained for each css mutant pro-
vided strong clues for the molecular identities of the CSS
genes. The accumulation of PtdEtn at the expense of PtdCho
strongly implicated css1 mutations as alleles of CHO2, the
PtdEtn methyltransferase structural gene (Figure 1A). This
enzyme catalyzes the methylation of PtdEtn to produce
PMME. The observed accumulation of both PMME and
PDME in lieu of PtdCho suggested that css2 mutations are
OPI3 alleles. OPI3 encodes a distinct phospholipid methyl-
transferase, which catalyzes the methylation of PMME to
PDME and PDME to PtdCho (Figure 1A). Finally, the css3
profiles, when coupled with their inositol-dependent css
phenotypes, strongly suggested these are hypomorphic al-
leles of INO2 or INO4. These genes encode transcription
factors required for expression of not only CHO2 and OPI3
Figure 1. (A) The two pathways for PtdCho biosynthesis in yeast. Mutations in CDP-choline pathway, but not in PtdEtn-methylation
pathway, suppress the essential requirement of Sec14p for Golgi secretory function and cell viability. CDP-choline pathway activity is
supported by endogenous choline derived from PtdCho turnover, and by exogenous choline, which is captured by the choline transporter.
In the absence of exogenous choline, PtdCho turnover represents the sole pathway for choline production. Genetic designations for the
structural genes encoding enzymes for PtdCho synthesis and turnover are given at the corresponding execution points. The role of the choline
transporter is also illustrated. (B) Choline-sensitive suppressors of sec14 (css). Indicated strains were patched on YPD plate and incubated at
26°C for 24 h. The cell patches were then replica plated onto minimal plates supplemented with 1 mM inositol but no choline (I1C2), or with
1 mM inositol and choline at indicated concentrations (I1 5 mM Cho and I1 10 mM Cho), or neither inositol nor choline (I2C2). The replica
plates were then incubated at 37°C for 48 h. Isogenic strains were used: CTY182 (wild-type), CTY1-1A (sec14-1ts), CTY1374 (sec14-1ts css1),
CTY1375 (sec14-1ts css2), CTY1473 (sec14-1ts css3).
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but also of INO1 whose product is required for de novo
synthesis of inositol in yeast.
That css1, css2, and css3 mutations represent alleles of
CHO2, OPI3, and INO4, respectively, is formally demon-
strated by the collective weight of three lines of evidence.
First, we find that low copy plasmids bearing individual
CHO2, OPI3, or INO4 genes specifically complement css1,
css2, and css3 mutations, respectively. Second, we find that
naive cho2D, opi3D, and ino4D alleles themselves exhibit css
phenotypes when introduced into sec14-1ts strains (our un-
published data). Third, meiotic segregation analyses indi-
cate a tight genetic linkage between css1 and cho2D::HIS3,
css2 and opi3D::HIS3, and css3 and ino4D::URA3. In these
linkage experiments, diploid strains CTYD174 (css1 s14-1ts/
cho2D sec14-1ts), CTYD175 (css2 sec14-1ts/opi3D sec14-1ts),
and CTYD176 (css3 sec14-1ts/ino4D sec14-1ts) were generated
(Table 1). Each of these diploids exhibits css phenotypes,
consistent with CSS1/CHO2, CSS2/OPI3, and CSS3/INO4 al-
lelic assignments. Analysis of at least 20 tetrads derived
from each diploid confirmed these allelic assignments. In all
cases, only parental di-type asci were recovered (4:0 css
[Ts1]:0 CSS [ts2] spores). From this point forward, we use
the CHO2, OPI3, and INO4 genetic nomenclature for CCS1,
CSS2, and CSS3, respectively.
Because ino4 mutations were encountered in the screen for
css mutants, and because the INO4 and INO2 gene products
cooperate in regulating expression of CHO2 and OPI3, we
also tested whether ino2D mutations elicit css phenotypes.
As expected, sec14-1ts ino2D strains closely resemble sec14-1ts
ino4D mutants from the standpoint that these exhibit css
phenotypes that are considerably weaker than those associ-
ated with either sec14-1ts cho2 or sec14-1ts opi3 strains (our
unpublished data). Although both the INO4 and INO2 gene
products are required for optimal expression of CHO2 and
OPI3, ino4D and ino2D mutations result in only modest
reductions in PtdEtn-methylation pathway activity in vivo
(Figure 2, A and B; unpublished data). Because ino4D and
ino2D mutants exhibit the weakest css phenotypes, these
collective data indicate that strength of the css phenotype is
inversely proportional to PtdEtn-methylation pathway ac-
tivity. In the following characterizations, we limit our anal-
yses to cho2 and opi3 mutants.
PtdEtn-Methylation Pathway Defects Efficiently
Restore Growth to Sec14p-deficient Yeast When
Choline Reuptake Is Blocked by Inactivation of the
Choline Transporter
Because PLD is activated in Sec14p-deficient yeast cells, we
considered the possibility that PLD activity and the efficient
recapture of excreted choline cooperate to drive CDP-cho-
line pathway activity when yeast are grown in choline-free
media. We reasoned that such a choline reuptake mecha-
nism might obscure bypass Sec14p phenotypes that would
otherwise be associated with defects in PtdEtn-methylation
pathway function. A basic prediction of this hypothesis is
that prevention of choline reuptake will potently improve
the ability of PtdEtn-methylation pathway defects to pro-
mote Sec14p-independent cell growth.
To test this hypothesis, we determined whether disrup-
tion of the single high-affinity choline transporter of yeast
(HNM1 gene product; Nikawa et al., 1990) improves growth
of sec14-1ts cho2 and sec14-1ts opi3 strains at 37°C. The phe-
notypic data clearly demonstrate that hnm1D not only sig-
nificantly improves the growth of sec14-1ts cho2 and sec14-1ts
opi3 mutants on I1C2 plates but also enables these strains to
grow well on choline-rich I1C1 and YPD plates at 37°C
(Figure 3A). Hnm1p dysfunction completely blocks the up-
take of exogenous choline by yeast cells (Nikawa et al., 1990)
and also impedes the uptake of exogenous ethanolamine
(Nikawa et al., 1986). Because even high concentrations of
exogenous ethanolamine (1 mM) have no effect on the weak
rescue of sec14-1ts growth defects by cho2 and opi3 on I1C2
media at 35°C or 37°C (see above), we conclude that dimin-
ished choline reuptake is the basis for the observed effects.
Figure 2. Steady-state phospholipid profiles of css mutants in defined I1C1 media. Cells were grown for five to six generations at 26°C in
I1C1 (A) or I1C2 media (B) supplemented with [32P]orthophosphate to 10 mCi/ml. Bulk glycerophospholipids were extracted, resolved, and
quantitated by phosphorimaging. Incorporation of 32P into each phospholipid species is indicated as a percentage of total incorporation of
radiolabel into extractable phospholipid. Strains used were isogenic and included: CTY1-1A (sec14-1ts: black bars), CTY1374 (sec14-1ts css1;
hatched bars), CTY1375 (sec14-1ts css2, stippled bars), CTY1473 (sec14-1ts css3; open bars). These data represent the averages of three
independent experiments. PtdSer, phosphatidylserine.
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Combined Defects in Activities of the PtdEtn-
Methylation Pathway and the Choline Transporter
Bypass the Essential Cellular Requirement for
Sec14p
We used a plasmid shuffle strategy to determine whether the
combination of PtdEtn-methylation pathway mutations and
choline transporter defects is sufficient to effect rescue of
sec14D (see MATERIALS AND METHODS). We introduced
an hnm1D::URA3 allele into a sec14D::hisG strain (CTY1469)
carrying an endogenous YEp(SEC14 LEU2) plasmid that is
required for the viability of this strain because this plasmid
covers the unconditionally lethal sec14D::hisG allele. Subse-
quently, either cho2D::HIS3 or opi3D::HIS3 alleles were intro-
duced into CTY1469 under conditions where the YEp(SEC14
LEU2) plasmid was subject to selection for leucine prototro-
phy. These cho2D::HIS3 and opi3D::HIS3 derivative strains
(CTY1470 and CTY1471; Table 1) were then streaked onto
YPD plates to relieve the nutritional selection pressure for
YEp(SEC14 LEU2). The ability of these yeast strains to spon-
taneously cure the plasmid was assessed by monitoring the
recovery of white colonies/colony sectors that exhibited
unselected Leu2 phenotypes. We find that, although the
parental control strain CTY1469 is unable to cure the plas-
mid, both CTY1470 and CTY1471 readily do so. These data
demonstrate that cho2D::HIS3 and opi3D::HIS3 alleles exert
efficient bypass Sec14p phenotypes under conditions where
choline uptake/reuptake is prevented. Remarkably, hnm1D
renders deficiency in PtdEtn-methylation pathway function
as potent a mechanism for bypass Sec14p as is CDP-choline
pathway dysfunction.
PtdEtn-Methylation Pathway Defects Restore
Growth to Sec14p-deficient Yeast in Liquid Media
Our demonstration that choline recapture dramatically at-
tenuates the bypass Sec14p phenotype of PtdEtn-methyl-
ation pathway deficiencies suggests that the context in
which bypass Sec14p mutants are selected has a significant
bearing on what types of bypass Sec14p mutants are recov-
ered. Initial selections involved plating of sec14-1ts cells and
selecting for revertants that grew as single colonies on solid
medium at 37°C (Cleves et al., 1989, 1991b). Efficient mech-
anisms of choline reuptake could potentially operate under
these conditions because diffusion of choline away from cells
is slower in choline-free agar than it is in the corresponding
liquid medium. However, choline recapture should be much
less efficient in liquid medium. Thus, PtdEtn-methylation
pathway defects are predicted to effect bypass Sec14p in
choline-free liquid medium, even in the face of choline trans-
porter activity.
To test this possibility, appropriate strains were picked
from freshly streaked YPD plates, inoculated into I1C2 me-
dia, and incubated at 37°C. Culture growth was monitored
by measuring the OD600 of the culture as a function of time.
The sec14-1ts strain exhibits an initial doubling time of ;6 h
after which it ceases growing (Figure 3B). The sec14-1ts opi3
strain, however, grows nearly as robustly as the wild-type
control strain under these conditions and the culture reaches
saturation ;12 h after inoculation (Figure 3B). Thus, in
contrast to what is observed on solid growth media, the opi3
allele efficiently rescues sec14-1ts-associated growth defects
when the test is performed in choline-free liquid media. As
expected, the hnm1D allele does not further improve the
growth of sec14-1ts opi3 strains in I1C2 liquid medium at
37°C (Figure 3B).
To confirm that extracellular choline is growth inhibitory
to the sec14-1ts opi3 strain, we supplemented a base I1C2
liquid medium with choline to final concentrations of 1 and
10 mM. The growth of sec14-1ts opi3 cells at 37°C in these
media was then assessed. Choline at a concentration of 1 mM
effects a marked inhibition of cell growth, whereas 10 mM
choline abolishes cell growth completely (our unpublished
data). These collective data indicate that a choline transporter-
mediated mechanism for choline recapture from the extracel-
lular milieu, and the subsequent salvage of recaptured choline
through the CDP-choline pathway for PtdCho biosynthesis,
significantly obscure the bypass Sec14p phenotype associated
with PtdEtn-methylation pathway dysfunction.
Demonstration of Choline Recapture on Solid Media
To test the idea that choline transporter activity mediates
efficient choline recapture when cells are cultured on solid
Figure 3 (facing page). (A) Prevention of choline uptake enables PtdEtn-methylation pathway dysfunction to efficiently suppress sec14-1ts
growth defects. Appropriate strains were streaked on indicated plates and incubated at 37°C for 48 h. Strains used were: CTY182 (wild type),
CTY1-1A (sec14-1ts), CTY1374 (sec14-1ts cho2), CTY1375 (sec14-1ts opi3), CTY1498 (hnm1D::URA3), CTY1499 (sec14-1ts hnm1D::URA3), CTY1500
(sec14-1ts cho2 hnm1D::URA3), CTY1501 (sec14-1ts opi3 hnm1D::URA3). (B) PtdEtn-methylation pathway mutations efficiently restore growth to
the sec14-1ts strain at 37°C in liquid I1C2 media. Appropriate strains were picked up from freshly streaked YPD plates, inoculated into liquid
defined media supplemented with inositol but no choline, and incubated at 37°C with shaking. Aliquots were collected for determination of
OD600 at indicated times. Strains used were CTY182 (wild-type; closed diamonds), CTY1-1A (sec14-1ts; closed squares), CTY1375 (sec14-1ts
opi3; closed triangles), CTY1377 (sec14-1ts opi3 hnm1D::URA3; open triangles). (C) Choline recapture visualized by cross-feeding. Patches of
a sec14-1ts opi3 strain and a sec14-1ts opi3 hnm1D strain (choline feeders) were deposited on a lawn of sec14-1ts opi3 strain (indicator) on an I1C2
plate and incubated at 37°C for 36 h. The growth of indicator cells surrounding the sec14-1ts opi3 hnm1D feeder was inhibited, as indicated
by a halo surrounding the feeder. This inhibition did not occur when the sec14-1ts opi3 strain, which is competent for choline reuptake, was
used as feeder. No halo was observed when the incubation temperature is 26°C or when the sec14-1ts opi3 hnm1D strain was used as indicator.
Strains used were isogenic and included: CTY1375 (sec14-1ts opi3), CTY1500 (sec14-1ts opi3 hnm1D::URA3). (D) Rate of PtdCho biosynthesis via
CDP-choline pathway correlates with the suppression of sec14 growth defects in I1C1 or I1C2 media. Indicated strains were cultured to early
logarithmic phase at 26°C in either I1C1 (black bars) or I1C2 minimal media (open bars). Cultures were subsequently shifted to 33.5°C for
1 h, and pulse-radiolabeled with [32P]orthophosphate (10 mCi/ml) at 33.5°C for 20 min. Bulk glycerophospholipids were extracted, resolved,
and quantitated by phosphoimaging. Incorporation of 32P into each phospholipid species is indicated as a percentage of total incorporation
of radiolabel into extractable phospholipid. The strains used were isogenic and included: CTY182 (wild-type), CTY1-1A (sec14-1ts), CTY102
(sec14-1ts pct1-2), CTY1374 (sec14-1ts cho2), CTY1499 (sec14-1ts hnm1D::URA3), CTY1500 (sec14-1ts cho2 hnm1D::URA3). These data represent
averages from at least three independent experiments.
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I1C2 medium, we designed a sensitive bioassay to score the
net leakage of choline from cells in the presence and absence
of the choline transporter. The exquisite sensitivity of sec14-
1ts opi3 strains to the growth inhibitory effects of exogenous
choline at restrictive temperatures (Figure 1B) forms the
basis for a cross-feeding assay designed to demonstrate a
paracrine uptake of excreted choline. In this assay, we de-
posited a heavy bolus of sec14-1ts opi3 or sec14-1ts opi3 hnm1D
yeast cells (as choline feeders) onto a lawn of sec14-1ts opi3
cells (as indicator) on I1C2 plates, and incubated the plates
at 37°C for 36 h. These incubation conditions result in PLD
activation and subsequent stimulation of PtdCho hydrolysis
to PtdOH and free choline. Leakage of choline from the
feeder colony is manifested by the inhibition of growth of
the surrounding indicator cells. As shown in Figure 3C, no
halo of inhibition is formed when the feeder possesses a
wild-type HNM1 gene. This result indicates that little if any
choline escaped from the feeder colony. By contrast, intro-
duction of hnm1D into the feeder strain results in formation
of a clearly discernable halo surrounding the feeder colony.
Experiments where sec14-1ts cho2 cells are used as feeder, or
where sec14-1ts cho2 cells are used as indicator yield similar
results (our unpublished data).
Measurements of PtdCho Synthesis
The collective results indicate that inhibition of choline re-
uptake is required for efficient down-regulation of PtdCho
synthesis in sec14-1ts cho2 and sec14-1ts opi3 mutants at 37°C.
We expected that choline recapture sustains PtdCho synthe-
sis by driving activity of the CDP-choline pathway. This
hypothesis predicts that metabolic flux through the CDP-
choline pathway is low in sec14-1ts cho2 and sec14-1ts opi3
mutants incubated under conditions permissive for bypass
Sec14p, but that CDP-choline pathway activity is high under
conditions restrictive for cho2- and opi3-mediated bypass
Sec14p.
We tested these predictions by monitoring CDP-choline
pathway activity in sec14-1ts cho2 mutants cultured in I1C2
and I1C1 media, i.e., permissive and restrictive conditions
for bypass Sec14p, respectively. We also performed these
experiments with hnm1D derivatives of these strains for
which bypass Sec14p is no longer a function of the choline
content of the medium. As positive and negative controls for
CDP-choline pathway activity, we used isogenic sec14-1ts
and sec14-1ts pct1 mutants, respectively. To measure meta-
bolic flux through the CDP-choline pathway without the
complication of adding radiolabeled choline to the medium,
we monitored the incorporation of 32P into PtdCho in a
20-min pulse radiolabeling experiment at a semipermissive
temperature for sec14-1ts strains (33.5°C). In this regimen,
PLD-dependent PtdCho turnover is stimulated and CDP-
choline pathway activity is the predominant contributor to
PtdCho synthesis (McGee et al., 1994; Rivas et al., 1999; Li et
al., 2000).
As shown in Figure 3D, a comparison of the rates of 32P
incorporation into PtdCho in SEC14 and sec14-1ts strains
cultured in I1C1 versus I1C2 medium demonstrates that
CDP-choline pathway activity is highly stimulated by inclu-
sion of choline in the medium. Of the total extractable lipid
phosphate, the wild-type strain cultured in I1C1 and I1C2
medium incorporates 27.7 6 1.3 and 2.0 6 0.17% of the 32P
radiolabel into PtdCho, respectively. For the isogenic sec14-
1ts strain, 40.3 6 5.5 and 17.3 6 1.3% of the radiolabel is
incorporated into PtdCho under these same conditions, re-
spectively. The increased rate of CDP-choline pathway ac-
tivity in the sec14-1ts strain is in agreement with previous
reports that Sec14p down-regulates this pathway (McGee et
al., 1994; Skinner et al., 1995). Genetic inactivation of the
CDP-choline pathway in the sec14-1ts pct1 mutant reduces
the rate of PtdCho biosynthesis to nearly undetectable levels
when cells are cultured in I1C1 or I1C2 medium (1.8 6 0.15
and 1.8 6 0.6% of extractable lipid 32P incorporated into
PtdCho, respectively). Introduction of the hnm1D allele into
the sec14-1ts mutant reduced CDP-choline pathway activity
in cells grown in I1C1 medium approximately fourfold
from 40.3 6 5.5 to 17.5 6 2.7% of extractable lipid 32P
incorporated into PtdCho, respectively. This level of incor-
poration was similar to that recorded for sec14-1ts hnm1D
cells incubated in choline-free medium (17.3 6 2.0%; Figure
3D). These levels of PtdCho synthesis are intermediate be-
tween the values recorded for the sec14-1ts and sec14-1ts pct1
mutants. The residual activity of the CDP-choline pathway
measured in the hnm1D derivatives likely represents salvage
of an intracellular choline pool that is generated by PtdCho
turnover, but is not excreted from the cells.
The PtdCho profile of the sec14-1ts cho2 mutant is essen-
tially indistinguishable from that of the isogenic sec14-1ts
control when the strains are incubated in I1C1 medium
(Figure 3D). However, CDP-choline pathway activity in the
cho2 mutant is clearly reduced relative to the positive control
when cells are incubated in I1C2 medium (6.5 6 0.31 versus
17.3 6 1.3 of extractable lipid 32P incorporated into PtdCho,
respectively). Introduction of the hnm1D lesion into the
sec14-1ts cho2 derivative reduces CDP-choline pathway ac-
tivity in cells grown in I1C1 medium (9.4 6 1.1% of extract-
able lipid 32P incorporated into PtdCho) to a level resem-
bling that recorded for sec14-1ts cho2 hnm1D cells incubated
in choline-free medium (7.7 6 1.9% of extractable lipid 32P
incorporated into PtdCho; Figure 3D). Thus, in accord with
expectations, metabolic flux through the CDP-choline path-
way is low when sec14-1ts cho2 mutants are incubated under
conditions permissive for bypass Sec14p, and CDP-choline
pathway activity is high under conditions restrictive for
cho2-mediated bypass Sec14p.
Golgi Secretory Function in Sec14p-deficient PtdEtn-
Methylation Pathway Mutants
To determine whether the bypass Sec14p phenotypes asso-
ciated with cho2 and opi3 alleles extend to rescue of sec14-
1ts-associated secretory defects, we used efficiency of inver-
tase secretion as an indicator of yeast secretory competence.
This measurement is quantified by an invertase secretion
index that relates the percentage of secreted invertase rela-
tive to the total amount of invertase produced by the cells
(Bankaitis et al., 1989; Franzusoff and Schekman, 1989;
Salama et al., 1990). In these experiments, we quantify the
secretory efficiencies of yeast strains cultured at 37°C in
I1C2 liquid growth media (i.e., conditions where cho2 and
opi3 alleles efficiently rescue sec14-1ts-associated growth de-
fects). These values are then compared with the correspond-
ing secretory efficiencies measured in I1C1 liquid media
(i.e., restrictive conditions for cho2- and opi3-mediated rescue
of sec14-1ts growth defects).
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Wild-type yeast cells secreted invertase rapidly and effi-
ciently when cultured in either I1C2 or I1C1 liquid media.
As shown in Figure 4A, the secretion indices for the wild-
type strain are 99 6 7.0 and 98.7 6 6.1% in I1C2 and I1C1
conditions, respectively. By contrast, the secretion index for
the isogenic sec14-1ts strain is 21.7 6 5.1% in I1C1 medium.
This reduced secretory index reflects accumulation of inver-
tase in the lumen of the yeast Golgi complex. Interestingly,
the secretion index of the sec14-1ts strain is modestly, but
significantly, improved to 36.6 6 4.7% simply by culturing
the strain in I1C2 medium (Figure 4A).
Secretion indices recorded for the sec14-1ts cho2 and
sec14-1ts opi3 strains cultured in I1C1 medium are 21.0 6
4.1 and 19.2 6 2.1%, respectively. These values are indis-
tinguishable from those measured for the isogenic sec14-
1ts strain cultured under the same conditions, and these
secretory defects are consistent with the choline-sensitive
growth of cho2 and opi3 strains at temperatures restrictive
for function of the sec14-1ts gene product. By contrast, the
invertase secretion indices of the sec14-1ts cho2 and sec14-
1ts opi3 strains cultured in I1C2 liquid medium are 87.2 6
4.4 and 81.7 6 9.1%, respectively (Figure 4A). These val-
ues are very similar to those recorded for the wild-type
strain, indicating that cho2 and opi3 individually restore
near wild-type efficiencies of invertase secretion to
Sec14p-deficient cells when these were cultured in cho-
line-free media. Introduction of hnm1D into sec14-1ts cho2
and sec14-1ts opi3 strains also restores wild-type invertase
secretion profiles to these mutants, regardless of the cho-
line-content of the medium (our unpublished data).
In an independent evaluation of Golgi secretory function,
we employed pulse-chase methods to monitor the trafficking
of carboxypeptidase Y (CPY) through the secretory pathway
to vacuole. As illustrated in Figure 4B, the wild-type strain
grown in either I1C1 or I1C2 liquid media accumulates
predominantly the 61 kDa mature form CPY (mCPY). Only
trace amounts of the 67 kDa and the 69 kDa endoplasmic
reticulum and Golgi precursor forms (p1 and p2 CPY, re-
spectively) are observed. Because mCPY represents the vac-
uolar form of the enzyme, these data demonstrate the rapid
trafficking of CPY through the yeast secretory pathway to
the vacuole.
The isogenic sec14-1ts mutant cultured in I1C1 medium,
however, accumulates ;70% of the total labeled CPY as p2
CPY (Figure 4B). These results diagnose the defective trans-
port of CPY from the Golgi complex in Sec14p-deficient
strains. This trafficking block is substantially relieved when
the sec14-1ts strain is challenged with the restrictive temper-
ature in I1C2 medium. Under these conditions, some 40% of
the total labeled CPY is in the p2 form, whereas the remain-
ing fraction is delivered to the vacuole and recovered as
mCPY (Figure 4B). Thus, as in the invertase secretion mea-
surements, simple omission of choline from the medium
effects a detectable suppression of the secretory defects as-
sociated with Sec14p deficiency.
When incubated in I1C1 medium at 37°C, sec14-1ts cho2
and sec14-1ts opi3 strains exhibit CPY profiles that are
indistinguishable from those recorded for the isogenic
sec14-1ts mutant. That is, ;70% of the total labeled CPY
accumulates in the p2 form. When the experiment is per-
formed in I1C2 medium, the CPY profiles of both the
sec14-1ts cho2 and sec14-1ts opi3 mutants are indistinguish-
able from those recorded for the wild-type strain. Nearly
all of the labeled CPY is recovered as mCPY (Figure 4B).
Figure 4. (A) Efficiency of invertase secretion at 37°C for PtdEtn-methylation pathway mutants grown in I1C1 (black bars) and I1C2 media
(open bars). Secretion index was calculated as (extracellular invertase/total invertase 3 100%) (Salama et al., 1990), and the values presented
represent the averages of triplicate determinations from at least three independent experiments. The secretion indices of wild-type strain and
sec14-1ts strain represent the secretory efficiency under Sec14p-proficient and Sec14p-deficient conditions, respectively. Strains used were
CTY182 (wild type), CTY1-1A (sec14-1ts), CTY1374 (sec14-1ts cho2), CTY1375 (sec14-1ts opi3). (B) Trafficking of CPY through the secretory
pathway to vacuole in I1C1 and I1C2 media. Appropriate strains were grown at 26°C to early logarithmic phase in the indicated media (I1C1
media are indicated by “1” and I1C2 media was indicated by “2” below the lane), shifted to 37°C for 2 h, and pulse-radiolabeled with
35S-amino acids at 37°C for 30 min. Radiolabeled CPY species were recovered, resolved, and quantitated as described (Fang et al., 1996). The
p1 (ER), p2 (Golgi), and mature vacuolar (m) forms of CPY are indicated at right. Strains used included CTY182 (wild type), CTY1-1A
(sec14-1ts), CTY1374 (sec14-1ts cho2), and CTY1375 (sec14-1ts opi3).
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Again, hnm1D restores wild-type efficiencies of CPY traf-
ficking to the vacuole in sec14-1ts cho2 and sec14-1ts opi3
strains irrespective of the choline content of the medium
(our unpublished data). These collective data emphasize
the point that PtdCho synthesis is toxic to yeast Golgi
secretory function in the absence of a functional Sec14p.
Evidence that at least one aspect of this toxicity involves
an intrinsic toxicity of PtdCho itself is presented below.
Bypass Sec14p Phenotype Associated with cho2
hnm1D and opi3 hnm1D Alleles Is PLD-dependent
We previously demonstrated that all known pathways for
bypass Sec14p exhibit the dual requirement for PLD cata-
lytic activity, and an ability of PLD to properly access its
PtdCho substrate in vivo (Xie et al., 1998). It was therefore of
interest to determine whether the bypass Sec14p effected by
PtdEtn-methylation pathway defects exhibits a similar PLD
Figure 5. Role of phospholipase D in suppression of sec14 defects by PtdEtn-methylation pathway dysfunction. (A) Role of PLD (SPO14
gene product). The indicated strains were streaked onto YPD plates, incubated at 37°C for 48 h, and the growth of each strain was then
recorded. Isogenic strains were used and these included CTY1499 (sec14-1ts hnm1D::URA3), CTY1502 (hnm1D::HIS3), CTY1504 (sec14-1ts cho2
hnm1D::HIS3), CTY1505 (sec14-1ts opi3 hnm1D::HIS3), CTY1506 (hnm1D::HIS3 spo14D::URA3), CTY1507 (sec14-1ts hnm1D::URA3 spo14D::HIS3),
CTY1512 (sec14-1ts cho2 hnm1D::HIS3 spo14D::URA3), CTY1513 (sec14-1ts opi3 hnm1D::HIS3 spo14D::URA3). (B) The catalytic activity of PLD is
necessary, but not sufficient, for the suppression of sec14 defects by PtdEtn-methylation pathway defects. The sec14-1ts opi3 hnm1D::URA3
spo14D::URA3 strain and its derivative strains carrying either a wild-type SPO14 gene on low copy plasmid (YCp), or a mutant spo14 gene
on low copy plasmid (YCp) or high copy plasmid (YEp), were streaked on YPD plates and incubated at 37°C for 48 h. The growth of each
strain was then recorded. Strains used included CTY1485 (sec14-1ts opi3 hnm1D::URA3 spo14D::URA3); CTY1519 (CTY1485/YCpSPO14);
CTY1520 (CTY1485/YCp spo14K3H); CTY1521 (CTY1485/YCp spo14DN); CTY1522 (CTY1485/YEp spo14K3H); CTY1523 (CTY1485/YEp
spo14DN). (C) Plb1p overexpression improves growth of sec14-1ts mutants at a nonpermissive temperature. Isogenic yeast strains CTY182
(SEC14) and CTY1–1A (sec14-1ts) were transformed with the indicated YEp plasmids. Transformants were isolated and streaked for isolated
colonies on YPD medium at 35°C. Growth was scored after 48 h of incubation. Relevant genotypes are shown. The SEC14/YEp(URA3) and
sec14-1ts/YEp(URA3) strains represented positive and negative controls for growth, respectively.
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requirement. To investigate this issue, a spo14D allele was
introduced into sec14-1ts cho2 hnm1D and into sec14-1ts opi3
hnm1D strains, and the growth phenotypes of these strains
were assessed on YPD plates at 37°C. As shown in Figure
5A, spo14D has no effect on the growth of the SEC14 hnm1D
control strain, but this mutation prevents growth of both the
sec14-1ts cho2 hnm1D and the sec14-1ts opi3 hnm1D strain.
Neither expression of a catalytic-dead spo14K3H PLD form
(Sung et al., 1997) nor of a catalytically active form of PLD
that fails to localize to membranes (spo14DN ;Rudge et al.,
1998), complements the spo14D-associated ts2 growth phe-
notype of these strains (Figure 5B). Finally, this acquired ts2
phenotype reflects a reimposition of a Sec14p requirement
for growth as evidenced by the fact that SEC14 cho2 hnm1D
spo14D and SEC14 opi3 hnm1D spo14D mutants grow well
under these conditions (unpublished data).
These data indicate that bypass Sec14p phenotypes asso-
ciated with PtdEtn-methylation pathway defects require the
participation of a catalytically active PLD that retains the
ability to efficiently interface with its PtdCho substrate in
vivo.
Relative Efficiencies of Plb1p and Pik1p
Overexpression in Rescue of sec14-1ts-associated
Growth Defects
PLD catalyzes hydrolysis of PtdCho to produce PtdOH and
choline. PLD activity may support the suppression by the
breakdown of PtdCho, or by the generation of a downstream
metabolite PtdOH/DAG, or both. Present evidence indi-
cates that generation of a downstream metabolite is a con-
tributing factor to bypass Sec14p (Xie et al., 1998; Rivas et al.,
1999). Yeast express a PLB1 gene that encodes a protein with
both phospholipase B and lysophospholipase activity. Plb1p
catalyzes a concerted deacylation of PtdCho and PtdEtn to
glycerophosphocholine and glycerophosphoethanolamine,
respectively. These compounds are generated without for-
mation of a discrete lysophospholipid intermediate, and are
excreted into the medium (Lee et al., 1994; Whit et al., 1994).
To determine whether Plb1p-mediated PtdCho hydrolysis
modulates sec14-1ts-associated growth defects, we constructed
a multicopy plasmid that directs expression of PLB1 via the
powerful promoter of the yeast phosphoglycerate kinase struc-
tural gene (PGK). This plasmid, YEp(PPGK::PLB1), was intro-
duced into a sec14-1ts strain and its phenotypic effects were
determined. Our expectation was that Plb1p would serve as a
negative control in experiments studying the relationship be-
tween PtdCho turnover and Sec14p function. Because this
phospholipase is predicted to localize to the plasma membrane
in an orientation where its active site is exposed to the noncy-
toplasmic leaflet of this membrane (Whit et al., 1984; Lee et al.,
1994), we expected that Plb1p activity would be irrelevant to
any Sec14p-dependent pathway. Surprisingly, we found that
YEp(PPGK::PLB1) clearly improved the growth of sec14-1ts
strains at restrictive temperatures. As shown in Figure 5C, the
parental sec14-1ts strain does not grow at all when incubated at
35°C. The YEp(PPGK::PLB1) derivative, however, grows at this
temperature and forms isolated colonies. The growth rate is
significantly slower than that exhibited by the isogenic wild-
type strain. Moreover, YEp(PPGK::PLB1) only partially rescues
sec14-1ts growth defects because the effect is not observed at
37°C.
We cannot provide a precise rationale for this unantici-
pated result, given the expected topology of Plb1p. Perhaps
yeast cells accelerate a flipping of PtdCho from the cytoplas-
mic leaflet of the plasma membrane (or other intracellular
membranes, such as the Golgi complex) to the opposing
leaflet when a PtdCho deficit is imposed upon the noncyto-
plasmic leaflet. Alternatively, Plb1p overproduction might
result in sustained levels of active Plb1p in the cytoplasm,
thereby promoting the abnormal deacylation of PtdCho in
the cytoplasmic leaflet of intracellular membranes.
The idiosyncratic nature of the effect notwithstanding,
YEp(PPGK::PLB1) effects a stronger suppression of sec14-1ts
growth defects than does a YEp(PIK1) plasmid, which drives
overexpression of the Pik1p PtdIns 4-kinase (Walch-Soli-
mena and Novick, 1999). Hama et al. (1999) reported that
YEp(PIK1) suppresses sec14-1ts growth defects at 34°C and
interpreted that result to indicate that the critical function of
Sec14p is to stimulate Pik1p-dependent synthesis of PtdIns-
4-phosphate. We do not find that YEp(PIK1) exerts a signif-
icant effect on sec14-1ts-associated growth defects at 34 or
35°C, yet YEp(PPGK::PLB1) clearly does (Figure 5C). Because
Plb1p deacylates PtdCho to products that cannot be directly
metabolized to PtdOH or DAG, we conclude that the benefit
realized by Sec14p-deficient mutants overproducing Plb1p
is related to PtdCho hydrolysis itself. These data suggest an
intrinsic toxicity of PtdCho to Sec14p-dependent Golgi func-
tion in yeast. This result agrees with our previous demon-
stration that a mutant Sec14p that retains only its PtdCho-
transfer activity, and its ability to down-regulate PtdCho
synthesis via the CDP-choline pathway in vivo, fulfills all
essential Sec14p functions in vivo (Phillips et al., 1999).
DISCUSSION
Herein, we describe a body of evidence that indicates an
intrinsic toxicity of PtdCho to Golgi function in yeast. The
data support the concept that a primary function of Sec14p
is to modulate PtdCho biosynthesis so that an appropriate
balance is maintained between PtdCho production and a
Golgi PtdCho content that is permissive for protein trans-
port from this organelle. Our data also provide a solution to
the long-standing puzzle for why defects in the CDP-choline
pathway for PtdCho biosynthesis efficiently effect bypass
Sec14p, whereas defects in PtdCho synthesis via the PtdEtn
methylation pathway do not (Cleves et al., 1991b). Namely,
that a cycle of PtdCho turnover, coupled to choline excretion
and reuptake, activates the CDP-choline pathway and ob-
scures the bypass Sec14p phenotype that would normally be
associated with inactivation of the PtdEtn-methylation path-
way (Figure 6).
Initial clues regarding pathways for bypass Sec14p that
involve PtdEtn-methylation dysfunction came from a ge-
netic screen we had originally devised for the purpose of
detecting mutations that compromise PtdCho turnover (Xie
et al., 1998). Of the three genes identified by this screen, we
found that two correspond to CHO2 and OPI3, i.e., struc-
tural genes that encode for distinct phospholipid methyl-
transferases that are involved in the de novo production of
PtdCho from PtdEtn. The third gene encodes a transcription
factor, Ino4p, that has long been known to cooperate with its
Ino2p binding partner in driving optimal expression of
phospholipid biosynthetic genes such as CHO2 and OPI3
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(Carman and Zeimetz, 1996). Subsequent tests indicated that
ino2 mutations also satisfy the genetic screen. This outcome
demonstrates that the assumptions upon which that genetic
screen was founded were imprecise. In retrospect, we now
appreciate that this screen points the way toward identify-
ing novel pathways for bypass Sec14p that involve the com-
binatorial interface of pathways for PtdCho biosynthesis,
turnover, and mechanisms of choline salvage.
Detailed analyses of these mutant phenotypes reveal un-
expected aspects of yeast physiology as these pertain to
choline metabolism. Our data indicate that a significant
fraction of the choline generated via PLD-mediated hydro-
lysis of PtdCho is excreted from cells. The fate of this ex-
creted choline determines the activity of the CDP-choline
pathway, which functions to scavenge whatever excreted
choline is recaptured and reincorporates it into PtdCho. The
salvage activity of the CDP-choline pathway fueled by re-
captured choline is of primary significance to the phenotypic
effects of the PtdEtn methylation pathway as these relate to
bypass Sec14p. Under conditions where choline recapture is
favored, such as incubation of cells on solid choline-free
medium (I1C2 plates) or when the yeast high-affinity cho-
line transporter is functional, choline salvage is efficient and
the CDP-choline pathway is active. That metabolic flux
through the CDP-choline pathway obscures the bypass
Sec14p phenotype that would otherwise be associated with
PtdEtn-methylation pathway inactivity.
By contrast, cells grown in choline-free liquid media face
a rapid outward diffusion of excreted choline into the envi-
ronment. In cultures with a relatively low cell density, ex-
creted choline rapidly dilutes to concentrations below the
Km of the transporter (1 mM; Nikawa et al., 1990). These
conditions do not favor choline recapture, the CDP-choline
pathway remains largely inactive, and PtdEtn-methylation
pathway dysfunction supports Sec14p-independent cell
growth and Golgi secretory function. Inactivation of the
choline transporter generates the same condition and, in that
circumstance, the bypass Sec14p phenotype associated with
PtdEtn-methylation pathway defects becomes choline-resis-
tant.
These various data satisfactorily account for why muta-
tions that inactivate the PtdEtn-methylation pathway were
not recovered in the classical bypass Sec14p mutant selec-
tions of Cleves et al. (1989, 1991b). Those selections were not
only performed in choline-replete medium at 37°C, but used
agar plates for both mutant selection and phenotypic char-
acterization of mutants. In addition, directed tests of
whether PtdEtn-methylation pathway defects could effect
bypass Sec14p were performed on I1C2 plates at 37°C
(Cleves et al., 1991b). It is now clear that selection of bypass
Sec14p mutants in I1C2 liquid medium does yield mutants
individually deficient in activity of either the CDP-choline
pathway or the PtdEtn pathway for PtdCho biosynthesis.
Finally, our demonstration that genetic inactivation of
either pathway for PtdCho biosynthesis can result in bypass
Sec14p, and that accelerated rates of Plb1p-driven PtdCho
hydrolysis effect partial suppression of sec14-1ts-associated
growth defects, make a case that PtdCho is intrinsically toxic
to Golgi function in yeast. This finding supports our early
model that Sec14p acts to reduce Golgi PtdCho content
(Cleves et al., 1991a,b). This finding also forces us to recon-
sider our later models that the CDP-choline pathway is
uniquely toxic to Golgi secretory function solely on the basis
of its consumption of a critical metabolic precursor (i.e.,
DAG; McGee et al., 1994; Kearns et al., 1997; Rivas et al.,
1999). Elucidation of the details for why PtdCho is toxic to
yeast Golgi function now defines an important area for
future study.
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